Estimating Effectiveness of Influenza and COVID-19 Vaccines: The “Test-Negative” Design - Summary - MDSpire

Estimating Effectiveness of Influenza and COVID-19 Vaccines: The “Test-Negative” Design

  • By

  • Josh Michaud

  • Jennifer Kates

  • April 30, 2026

  • 0 min

Share

Objective:

Add relevance of the test-negative design in public health discussions.

Key Findings:
  • Include specific examples or data to enhance credibility.
Interpretation:

Elaborate on the value of the test-negative design for respiratory diseases.

Limitations:
  • Provide examples of potential confounding factors.
Conclusion:

Reiterate the importance of addressing limitations in future research.

Original Source(s)

Estimating Effectiveness of Influenza and COVID-19 Vaccines: The “Test-Negative” Design

  • by Josh Michaud, Jennifer Kates

  • April 30, 2026

Related Content

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

Hantavirus Outbreak Revives COVID-Era False Health Claims — The Monitor

Stewardship Cuts Steroid Prescribing

Behaviorally informed peer comparison feedback was associated with a gradual decline in glucocorticoid prescribing